Estrogen News and Research

Latest Estrogen News and Research

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

A new editorial paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?"

21 Aug 2023

Anti-estrogenic therapies can suppress growth of ER-negative cancers

Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.

21 Aug 2023

Some early-stage, low-risk breast cancer patients may not need radiotherapy after surgery

Some women with early-stage, low-risk breast cancer may not need radiotherapy after breast conserving surgery according to new research led by McMaster University, BC Cancer, Hamilton Heath Sciences, and the University of British Columbia.

16 Aug 2023

Scientist receives $6.8M grant to study how environmental chemicals increase CVD risk

Exposure to environmental chemicals, including those in common plastic products, has been linked with an increased risk of cardiovascular disease, or CVD, the leading cause of death worldwide. According to the World Health Organization, 17.9 million people died from CVDs in 2019.

16 Aug 2023

$Study suggests Vitamin D prescription lowers hip fracture incidence$

Study suggests Vitamin D prescription lowers hip fracture incidence

Researchers examined the relationship between vitamin D supplementation and osteoporosis-related fracture incidence.

14 Aug 2023

The role of estrogen in osteoarthritis and lower back pain

Researchers review existing evidence on the association between estrogen, osteoarthritis, and lower back pain.

10 Aug 2023

New treatment approach shows promise in reversing hormone resistance in breast cancer

A collaborative study between LSU Health New Orleans School of Medicine, the University of Rochester and Cellestia Biotech AG, a biopharmaceutical company headquartered in Basel, Switzerland, provides compelling evidence that combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases Rx effectiveness in experimental models of estrogen-receptor positive (ER+) and triple-negative breast cancers (TNBC), respectively.

9 Aug 2023

The impact of epigenetic features on breast cancer treatment and outcomes

The impact of epigenetic features on breast cancer treatment and outcomes.

9 Aug 2023

High-level BPA exposure may affect male fertility

Scientists discuss the effect of bisphenol A on human male fertility.

9 Aug 2023

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer

The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.

7 Aug 2023

Recent advances in the understanding of the role and mechanism of CCAR2 in cancer

Researchers described the dual role of cell cycle and apoptosis regulator 2 (CCAR2) in cancer progression as a tumor suppressor and promoter.

4 Aug 2023

Breast Cancer Now-funded research aims to improve quality of care for black women with breast cancer

Researchers are investigating how to improve the quality of care for black women with breast cancer and reduce health inequalities, thanks to funding from Breast Cancer Now.

2 Aug 2023

The effects of oxidative stress on women’s fertility

Scientists review existing literature to assess the relationship between oxidative stress and female infertility.

1 Aug 2023

Black women weigh emerging risks of ‘creamy crack’ hair straighteners

Deanna Denham Hughes was stunned when she was diagnosed with ovarian cancer last year. She was only 32. She had no family history of cancer, and tests found no genetic link. Hughes wondered why she, an otherwise healthy Black mother of two, would develop a malignancy known as a "silent killer."

1 Aug 2023

Newly identified protein plays a key role in the action of emerging anticancer therapies

Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

31 Jul 2023

Core promoter variation may drive development of triple-negative breast cancer

TNBC is a particularly aggressive subtype of breast cancer, characterized by the absence of three key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).

26 Jul 2023

Toxic metal cadmium could be linked to the development of endometriosis, study suggests

Women with a history of endometriosis had higher concentrations of cadmium in their urine compared to those without that diagnosis, according to a Michigan State University study that suggests the toxic metal could be linked to the development of endometriosis.

24 Jul 2023

Once the new over-the-counter birth control pill is available, What about cost and coverage?

Last week, the FDA approved Opill, the first daily oral contraceptive that will be available for sale over the counter in stores as well as online. Reproductive health advocates hailed the groundbreaking approval as a step that can help millions of people avoid pregnancy, which is unintended nearly half the time in the United States.

19 Jul 2023

Research reveals overwhelming support for group consultations among women experiencing menopause: a promising step towards improving quality of life

Study surveyed the impact of menopause on women's health by examining women's perspectives and experiences.

19 Jul 2023

Breast cancer and MEN1: exploring the connection

Researchers evaluated the role of Multiple Endocrine Neoplasia 1 (MEN1) messenger ribonucleic acid (mRNA) in breast cancer

17 Jul 2023

Estrogen News and Research

Latest Estrogen News and Research

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

Anti-estrogenic therapies can suppress growth of ER-negative cancers

Some early-stage, low-risk breast cancer patients may not need radiotherapy after surgery

Scientist receives $6.8M grant to study how environmental chemicals increase CVD risk

Study suggests Vitamin D prescription lowers hip fracture incidence

The role of estrogen in osteoarthritis and lower back pain

New treatment approach shows promise in reversing hormone resistance in breast cancer

The impact of epigenetic features on breast cancer treatment and outcomes

High-level BPA exposure may affect male fertility

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer

Recent advances in the understanding of the role and mechanism of CCAR2 in cancer

Breast Cancer Now-funded research aims to improve quality of care for black women with breast cancer

The effects of oxidative stress on women’s fertility

Black women weigh emerging risks of ‘creamy crack’ hair straighteners

Newly identified protein plays a key role in the action of emerging anticancer therapies

Core promoter variation may drive development of triple-negative breast cancer

Toxic metal cadmium could be linked to the development of endometriosis, study suggests

Once the new over-the-counter birth control pill is available, What about cost and coverage?

Research reveals overwhelming support for group consultations among women experiencing menopause: a promising step towards improving quality of life

Breast cancer and MEN1: exploring the connection

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Estrogen News and Research

Latest Estrogen News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in